Expects “elevated levels” of investment in Q4. Expects “no material improvement” in Asia Pacific region for remainder of year. Says “making progress” towards resolution of talc litigation, but no update on timeline. Says capital allocation strategy “remains unchanged.” Sees 2025 tax rate “slightly lower” than 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Morning Movers: Banks trending upward following quarterly results
- JNJ Earnings: Johnson & Johnson Tops Q3 Estimates, Raises FY24 Sales Forecast
- Johnson & Johnson reported strong earnings beat, says Barclays
- Johnson & Johnson says shifting pipeline to high innovation, high growth markets
- Johnson & Johnson’s nipocalimab shows disease control in myasthenia gravis